Brief: Sorrento Reports Promising Results With Universal Chimeric MRNA COVID Vaccine
March 20 (Reuters) - Sorrento Therapeutics Inc SRNE.O :
* SORRENTO REPORTS PROMISING RESULTS WITH UNIVERSAL CHIMERIC
MRNA
COVID-19 VACCINE
* SORRENTO THERAPEUTICS - INTENDS TO DEVELOP AND SEEK EUA
APPROVAL
OF THIS NEXT-GENERATION MRNA VACCINE IN MEXICO AND OTHER
DEVELOPING COUNTRIES
* VACCINE ELICITS POTENT NEUTRALIZING ANTIBODIES AND
PROTECTION
AGAINST OMICRON (BA.1 AND BA.2) AND DELTA VARIANTS
Source text for Eikon: ID:nGNXbQfph4
Further company coverage: SRNE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sorrento Therapeutics
See all newsBrief: Scilex Holding Says US Bankruptcy Court Extended Lockup Period On Shares Of Scilex Stock
Company's PO box allows it to file for bankruptcy in Texas, judge rules
Latham, Jackson Walker avoid sanctions over bankruptcy forum shopping dispute (updated)
Latham, Jackson Walker avoid sanctions over bankruptcy forum shopping dispute
Brief: Sorrento Therapeutics Reduced U.S. Headcount From 215 To 128 on Sept. 20